Euro Q3 Consumer Health Earnings Preview: GSK, Sanofi, Bayer And Reckitt
Major Europe-based consumer health players GSK, Sanofi, Bayer and Reckitt continue to deal with the fallout of the COVID-19 pandemic while implementing long-term strategies to drive growth. This earnings preview highlights what to look out for as these four firms report their third-quarter results over the coming weeks.
You may also be interested in...
Bayer believes its Consumer Health business has the potential to grow at twice the rate of the global market in 2021 following a double-digit rise in sales in the second quarter.
Sanofi says a double-digit gain for its Consumer Healthcare business in Q2 is evidence its new category prioritization strategy is paying off.
GSK is continuing to invest in e-commerce and sees opportunities for online growth in its "underdeveloped" dietary supplements category. Better e-commerce sales helped to drive up GSK Consumer Healthcare's Q2 turnover by 7% at constant currencies.